Results 1 to 10 of about 22,412 (196)

Repeated in situ arterial thrombolysis in severe heparin-induced thrombocytopenia

Annals of Vascular Surgery - Brief Reports and Innovations, 2023
Unstructured abstract: There are no clear guidelines addressing the use of thrombolysis to treat acute limb ischemia in patients with heparin-induced thrombocytopenia.
Roxane Varone, Daniel Danzer
doaj   +2 more sources

Heparin-induced thrombocytopenia [PDF]

Current Medicine Research and Practice, 2021
Heparin-induced thrombocytopenia (HIT) is an adverse prothrombotic disorder caused by an immune response to complexes of platelet factor 4 and polyanions. The clinical relevance of HIT results from the wide use of heparin, which is the reason that the absolute number of patients affected by HIT is high.
Prakash Shastri, Shubhlesh Kumar
doaj   +3 more sources

HEPARIN INDUCED THROMBOCYTOPENIA

Zdravniški Vestnik, 2008
BACKGROUND Unfractionated heparin and low-molecular-weight-heparins are commonly prescribed drugsin everyday clinical practice for treatment or prevention of thrombotic diseases. Heparinis used also for providing patency of various catheters.
Matija Kozak, Tadeja Dovč Drnovšek, Tanja Gmeiner Stopar   +2 more
doaj   +3 more sources

Heparin-induced thrombocytopenia

Journal of Emergencies, Trauma and Shock, 2011
In the last 7 decades heparin has remained the most commonly used anticoagulant. Its use is increasing, mainly due to the increase in the number of vascular interventions and aging population.
Shaikh Nissar
doaj   +3 more sources

BUN and mortality in patients with heparin-induced thrombocytopenia: A retrospective cohort study. [PDF]

Sci Prog
Tu G, Cai Z, Zhu G, Huang M.
europepmc   +2 more sources

Low-molecular-weight heparin-induced thrombocytopenia with multisite embolism: successful management with argatroban and dabigatran – a case report and literature review [PDF]

Frontiers in Pharmacology
Heparin-induced thrombocytopenia (HIT) is a rare but potentially life-threatening complication, with an incidence ranging from approximately 0.2%–5.0%.
Huixin Zhao, Xiaowan Tang, Xitao Song
doaj   +2 more sources

Spontaneous Heparin-Induced Thrombocytopenia Following Orthopedic Surgery. [PDF]

Cureus
Korolyov A, Hu R.
europepmc   +3 more sources

Heparin-induced thrombocytopenia occurring early after living donor liver transplantation: a case report

Emergency and Critical Care Medicine, 2023
. Background. Thrombocytopenia commonly occurs early after liver transplantation. Heparin, usually administered as anticoagulant therapy for thrombosis, a common complication after liver transplantation, may cause heparin-induced thrombocytopenia ...
Naoya Iwasaki, Motohiro Sekino, Takanobu Hara, Akihiko Soyama, Masaaki Hidaka, Yusuke Kasai, Miki Suzumura, Hiroshi Araki, Rintaro Yano, Sojiro Matsumoto, Taiga Ichinomiya, Ushio Higashijima, Susumu Eguchi, Tetsuya Hara   +13 more
doaj   +1 more source

Heparin-Induced Thrombocytopenia

Annual Review of Medicine, 1989
Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse drug effect that is characterized by platelet activation, hypercoagulability, and a resulting increased risk for thrombosis, both venous and arterial. This disorder is autoimmune-like, because the target antigen is a multimolecular complex of the "self" protein, platelet factor 4, and
T E, Warkentin, J G, Kelton
  +13 more sources

Heparin-Induced Thrombocytopenia in a Patient With Extensive Venous Thrombosis and Complex Comorbidities. [PDF]

Cureus
Kassis MA, Adleh MH, Mahmah A, Oduibat R, Saleh AM.   +4 more
europepmc   +3 more sources